{"organizations": [], "uuid": "d2e33aa6f95befe5b31b7fa219c22d5db10e79ca", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/merck-ma-pg/pg-acquires-mercks-consumer-health-business-for-about-4-21-bln-idUSL3N1RW2A0", "country": "US", "domain_rank": 408, "title": "P&G acquires Merck's consumer health business for about $4.21 bln", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-19T07:13:00.000+03:00", "replies_count": 0, "uuid": "d2e33aa6f95befe5b31b7fa219c22d5db10e79ca"}, "author": "", "url": "https://www.reuters.com/article/merck-ma-pg/pg-acquires-mercks-consumer-health-business-for-about-4-21-bln-idUSL3N1RW2A0", "ord_in_thread": 0, "title": "P&G acquires Merck's consumer health business for about $4.21 bln", "locations": [], "entities": {"persons": [{"name": "shalini nagarajan", "sentiment": "none"}, {"name": "sunil nair", "sentiment": "none"}], "locations": [{"name": "crest", "sentiment": "none"}, {"name": "bengaluru", "sentiment": "none"}], "organizations": [{"name": "p&g", "sentiment": "negative"}, {"name": "merck", "sentiment": "negative"}, {"name": "min read", "sentiment": "none"}, {"name": "reuters staff", "sentiment": "none"}, {"name": "vicks", "sentiment": "none"}, {"name": "merck kgaa", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 19, 2018 / 4:16 AM / a minute ago P&G acquires Merck's consumer health business for about $4.21 bln Reuters Staff 1 Min Read \n  said on Thursday it has acquired the consumer health business of German pharmaceuticals company Merck KGaA for about 3.4 billion euros ($4.21 billion). \nThe acquisition enables P&G to add to its portfolio of existing consumer healthcare capabilities and brands such as Vicks, Metamucil, Pepto-Bismol, Crest and Oral-B. ($1 = 0.8080 euros) (Reporting by Shalini Nagarajan in Bengaluru; Editing by Sunil Nair)", "external_links": [], "published": "2018-04-19T07:13:00.000+03:00", "crawled": "2018-04-19T07:31:53.004+03:00", "highlightTitle": ""}